Panagora Asset Management’s Amicus Therapeutics FOLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$8.27M Sell
1,444,107
-811
-0.1% -$4.65K 0.04% 280
2025
Q1
$11.8M Buy
1,444,918
+10,641
+0.7% +$86.8K 0.06% 236
2024
Q4
$13.5M Buy
1,434,277
+4,934
+0.3% +$46.5K 0.06% 209
2024
Q3
$15.3M Sell
1,429,343
-1,580
-0.1% -$16.9K 0.07% 195
2024
Q2
$14.2M Sell
1,430,923
-98,239
-6% -$975K 0.07% 184
2024
Q1
$18M Buy
1,529,162
+131,850
+9% +$1.55M 0.09% 174
2023
Q4
$19.8M Sell
1,397,312
-33,112
-2% -$470K 0.11% 160
2023
Q3
$17.4M Buy
1,430,424
+96,980
+7% +$1.18M 0.11% 161
2023
Q2
$16.7M Sell
1,333,444
-33,521
-2% -$421K 0.1% 185
2023
Q1
$15.2M Buy
1,366,965
+123,604
+10% +$1.37M 0.1% 194
2022
Q4
$15.2M Buy
1,243,361
+32,356
+3% +$395K 0.1% 207
2022
Q3
$12.6M Buy
1,211,005
+112,208
+10% +$1.17M 0.09% 212
2022
Q2
$11.8M Buy
1,098,797
+92,665
+9% +$995K 0.08% 233
2022
Q1
$9.53M Buy
1,006,132
+35,951
+4% +$340K 0.05% 291
2021
Q4
$11.2M Buy
970,181
+238,275
+33% +$2.75M 0.06% 276
2021
Q3
$6.99M Buy
731,906
+128,051
+21% +$1.22M 0.04% 360
2021
Q2
$5.82M Buy
603,855
+308,267
+104% +$2.97M 0.03% 410
2021
Q1
$2.92M Sell
295,588
-228,601
-44% -$2.26M 0.02% 614
2020
Q4
$12.1M Sell
524,189
-504,395
-49% -$11.6M 0.07% 240
2020
Q3
$14.5M Sell
1,028,584
-480,968
-32% -$6.79M 0.09% 195
2020
Q2
$22.8M Sell
1,509,552
-35,267
-2% -$532K 0.15% 140
2020
Q1
$14.3M Buy
1,544,819
+1,065,675
+222% +$9.85M 0.1% 190
2019
Q4
$4.67M Buy
+479,144
New +$4.67M 0.02% 506
2016
Q1
Sell
-7,670
Closed -$74K 2308
2015
Q4
$74K Sell
7,670
-4,160
-35% -$40.1K ﹤0.01% 1876
2015
Q3
$165K Sell
11,830
-21,592
-65% -$301K ﹤0.01% 1661
2015
Q2
$473K Sell
33,422
-32,860
-50% -$465K ﹤0.01% 1350
2015
Q1
$721K Buy
+66,282
New +$721K ﹤0.01% 1190